Pableo, Mary Mae .

HRN: 22-66-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
METRONIDAZOLE 500MG (TAB)
05/03/2026
05/10/2026
PO
500
Q8
Thickly MSAf
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: